Cooper Profit Margins 2006-2018 | COO

Current and historical gross, operating and net profit margins for Cooper (COO) over the last 10 years. The current net profit margin for Cooper (COO) as of April 30, 2018 is 5.58%.
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.026B $2.139B
The Cooper Companies, Inc. is a global medical device company. Cooper is dedicated to being A Quality of Life Company with a focus on delivering shareholder value. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of families with its diversified portfolio of products and services focusing on women's health, fertility and diagnostics.
Stock Name Country Market Cap PE Ratio
Becton, Dickinson (BDX) United States $65.499B 24.54
Align Technology (ALGN) United States $29.037B 85.85
McKesson (MCK) United States $27.357B 10.73
AmerisourceBergen (ABC) United States $19.101B 13.90
Laboratory Of America Holdings (LH) United States $18.998B 18.35
Cardinal Health (CAH) United States $15.755B 9.94
Henry Schein (HSIC) United States $11.410B 20.21
DENTSPLY SIRONA (XRAY) United States $10.171B 17.07
West Pharmaceutical Services (WST) United States $7.244B 40.35
Merit Medical Systems (MMSI) United States $2.803B 42.12
Patterson (PDCO) United States $2.134B 13.41
CONMED (CNMD) United States $2.051B 35.68
STAAR Surgical (STAA) United States $1.359B 466.43
Atrion (ATRI) United States $1.120B 32.00
Invacare (IVC) United States $0.680B 0.00
Endologix (ELGX) United States $0.463B 0.00
Antares Pharma (ATRS) United States $0.423B 0.00
Lifevantage (LFVN) United States $0.136B 28.18
Aceto (ACET) United States $0.101B 4.09
Pro-Dex (PDEX) United States $0.029B 12.79
Milestone Scientific (MLSS) United States $0.027B 0.00
Retractable Technologies (RVP) United States $0.027B 0.00
Biolase (BIOL) United States $0.026B 0.00